QTRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. QTRX is in a weakening short-term trend (bearish MACD expansion, price slipping toward lower supports) and there are no proprietary buy signals or fresh news catalysts to justify an impatient entry today. While options positioning is call-heavy and could support a bounce, the extremely elevated implied volatility and deteriorating profitability/margins make the risk/reward unattractive for an immediate buy.
Price/Trend: QTRX is down ~4.93% today to 6.35 (pre-market -1.94%), underperforming the S&P 500 (-0.27%). Momentum: MACD histogram is negative (-0.0869) and negatively expanding, which supports a continuing bearish/weak momentum regime. RSI(6)=35.789 is leaning toward oversold but not deeply oversold, implying downside can still persist before a clean mean-reversion signal appears. Moving averages are converging, suggesting consolidation/indecision, but the MACD indicates this consolidation is resolving bearishly. Levels: Pivot 7.11 is well above spot (overhead supply). Near-term support is S1 6.417 (already slightly broken) and S2 5.988 (next downside magnet). Upside resistance levels are R1 7.803 and R2 8.232—meaning a bounce would first need to reclaim ~6.42–7.11 to improve the setup.
Analyst price target raised (Canaccord to $8 from $
suggests improved sector/coverage outlook into
Revenue growth in the latest quarter (2025/Q3 +12.34% YoY) shows top-line momentum.
Call-skewed options positioning (very low put/call ratios) can support a short-term bounce if selling pressure exhausts near S2 (~5.99).
Technical momentum is bearish (MACD negative and worsening) and price is breaking below near support (S1 6.417), increasing odds of a test of S2 (5.988).
Profitability is deteriorating: net loss expanded materially YoY and gross margin fell sharply.
No news/events in the past week—no clear near-term catalyst to reverse the tape.
Extremely high implied volatility suggests elevated risk of sharp downside moves and unstable price action.
Latest quarter: 2025/Q3. Revenue increased to $40.233M (+12.34% YoY), indicating continued sales growth. However, profitability worsened: net income was -$33.517M (loss expanded significantly YoY) and EPS was -$0.73 (loss widened). Gross margin dropped to 42.77% (-23.99% YoY), a notable deterioration that pressures the path to breakeven. Overall: top-line growth is positive, but margin compression and a larger loss are near-term negatives.
Recent change (2025-12-22): Canaccord raised the price target to $8 (from $5) but maintained a Hold rating, citing continued sector momentum into 2026. Wall Street-style view: Pros—improving sector backdrop and revenue growth; higher PT implies upside from current levels if execution improves. Cons—Hold rating reflects uncertainty, and the company’s margin and loss trajectory undermine conviction for aggressive buying at the current moment. Ownership/flows: Hedge funds and insiders are neutral (no significant recent trends). Politicians/Congress: No recent congress trading data available (no reported influential buying/selling signal).
